Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Amoeba stock

ALMIB.PA
FR0011051598
A14WL9

Price

0.94
Today +/-
+0.02
Today %
+2.36 %

Amoeba stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Amoeba stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Amoeba stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Amoeba stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Amoeba's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Amoeba Stock Price History

DateAmoeba Price
12/18/20240.94 undefined
12/17/20240.92 undefined
12/16/20240.90 undefined
12/13/20240.94 undefined
12/12/20241.02 undefined
12/11/20240.87 undefined
12/10/20240.85 undefined
12/9/20240.80 undefined
12/6/20240.76 undefined
12/5/20240.76 undefined
12/4/20240.77 undefined
12/3/20240.76 undefined
12/2/20240.74 undefined
11/29/20240.78 undefined
11/28/20240.81 undefined
11/27/20240.83 undefined
11/26/20240.84 undefined
11/25/20240.79 undefined
11/22/20240.77 undefined
11/21/20240.78 undefined
11/20/20240.79 undefined
11/19/20240.74 undefined

Amoeba Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Amoeba, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Amoeba from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Amoeba’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Amoeba. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Amoeba’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Amoeba’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Amoeba’s growth potential.

Amoeba Revenue, EBIT and net profit per share

DateAmoeba RevenueAmoeba EBITAmoeba Net Income
2026e3.55 M undefined-2.5 M undefined-5.04 M undefined
2025e8.67 M undefined1.73 M undefined0 undefined
2024e0 undefined-6.18 M undefined-6.65 M undefined
20230 undefined-14.04 M undefined-14.3 M undefined
20220 undefined-5.84 M undefined-8.02 M undefined
20210 undefined-5.58 M undefined-7.82 M undefined
20200 undefined-6.16 M undefined-8.16 M undefined
2019120,000 undefined-5.51 M undefined-7.25 M undefined
2018120,000 undefined-5.44 M undefined-7.22 M undefined
2017160,000 undefined-5.96 M undefined-6.23 M undefined
2016130,000 undefined-5.75 M undefined-5.77 M undefined
2015140,000 undefined-3.99 M undefined-4.02 M undefined
2014220,000 undefined-920,000 undefined-970,000 undefined
2013300,000 undefined-490,000 undefined-520,000 undefined
201280,000 undefined-220,000 undefined-250,000 undefined

Amoeba Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e
000000000000083
---------------62.50
---------------
000000000000000
000-4-5-6-7-7-8-7-8-14-60-5
----25.0020.0016.67-14.29-12.5014.2975.00-57.14--
3.773.773.774.495.7666.017.8916.217.7833.5749.28000
---------------
Details

Keystats

Revenue and Growth

The Amoeba Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Amoeba is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201220132014201520162017201820192020202120222023
                       
0.370.462.627.731210.243.464.764.977.285.530.52
0000020201010107.595.75
0.180.060.411.321.120.760.571.110.780.770.741.76
20906019062065040090100250280.65203.12
10104090130140270210350140573.05135.87
0.580.623.139.3313.8711.814.726.186.218.457.132.63
0.260.250.191.486.226.435.655.14.33.512.713.51
010103501401009070907079.09112.22
00000000007340
0.871.352.212.973.093.233.472.512.492.482.480.04
000000000000
000000000000
1.131.612.414.89.459.769.217.686.886.066.013.66
1.712.235.5414.1323.3221.5713.9313.8613.0914.5113.146.29
                       
505080110120120120250330410926.2993.2
1.321.324.4715.0628.828.9928.9935.0740.6245.8217.4113.12
-0.43-0.94-1.75-4.57-10.27-16.63-23.84-31.08-38.92-46.02-10.16-18.06
0000-204014000000
000000000000
0.940.432.810.618.6312.525.414.242.030.218.18-3.94
0.040.110.180.840.750.680.570.741.121.031.31.38
6090100310310440330210560370357.49309.52
0.050.840.260.430.380.370.310.670.040.120.212.65
00000000000.591.01
0.060.110.410.160.780.770.517.780.3712.232.32.13
0.211.150.951.742.222.261.729.42.0913.754.166.48
0.550.651.391.412.056.336.710.178.230.270.052.79
000000000000
101042039041047080507402809.85959.92
0.560.661.811.82.466.86.790.228.970.550.063.75
0.771.812.763.544.689.068.519.6211.0614.34.2310.23
1.712.245.5614.1423.3121.5813.9213.8613.0914.5112.46.29
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Amoeba provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Amoeba's financial health and stability.

Assets

Amoeba's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Amoeba must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Amoeba after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Amoeba's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20122013201420152016201720182019202020212022
000-4-5-6-7-7-8-7-8
00000002111
00000000000
000000001,00000
00000011222
0000000001,0000
00000000000
00-1-4-5-5-5-3-3-4-4
000-2-3000000
000-2-3000000
00000000000
00000000000
000004000-3-6
003111300541010
00411134-14342
----------1.00-
00000000000
00254-1-6100-1
-0.63-0.02-2.08-6.35-9.06-6.07-5.52-3.51-3.31-4.4-4.73
00000000000

Amoeba stock margins

The Amoeba margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amoeba. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amoeba.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Amoeba's sales revenue. A higher gross margin percentage indicates that the Amoeba retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Amoeba's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Amoeba's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Amoeba's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Amoeba. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Amoeba's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Amoeba Margin History

Amoeba Gross marginAmoeba Profit marginAmoeba EBIT marginAmoeba Profit margin
2026e-175 %-70.58 %-142.04 %
2025e-175 %20 %0 %
2024e-175 %0 %0 %
2023-175 %0 %0 %
2022-175 %0 %0 %
2021-175 %0 %0 %
2020-175 %0 %0 %
2019-175 %-4,591.67 %-6,041.67 %
201891.67 %-4,533.33 %-6,016.67 %
2017-6.25 %-3,725 %-3,893.75 %
2016-175 %-4,423.08 %-4,438.46 %
2015-175 %-2,850 %-2,871.43 %
2014-175 %-418.18 %-440.91 %
2013-175 %-163.33 %-173.33 %
2012-175 %-275 %-312.5 %

Amoeba Stock Sales Revenue, EBIT, Earnings per Share

The Amoeba earnings per share therefore indicates how much revenue Amoeba has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Amoeba earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amoeba's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amoeba’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amoeba's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Amoeba Revenue, EBIT and net profit per share

DateAmoeba Sales per ShareAmoeba EBIT per shareAmoeba Earnings per Share
2026e0.07 undefined0 undefined-0.1 undefined
2025e0.17 undefined0 undefined0 undefined
2024e0 undefined0 undefined-0.13 undefined
20230 undefined-0.28 undefined-0.29 undefined
20220 undefined-0.17 undefined-0.24 undefined
20210 undefined-0.31 undefined-0.44 undefined
20200 undefined-0.38 undefined-0.5 undefined
20190.02 undefined-0.7 undefined-0.92 undefined
20180.02 undefined-0.91 undefined-1.2 undefined
20170.03 undefined-0.99 undefined-1.04 undefined
20160.02 undefined-1 undefined-1 undefined
20150.03 undefined-0.89 undefined-0.9 undefined
20140.06 undefined-0.24 undefined-0.26 undefined
20130.08 undefined-0.13 undefined-0.14 undefined
20120.02 undefined-0.06 undefined-0.07 undefined

Amoeba business model

Amoeba SA is an innovative company that was founded in 2000 and is based in Switzerland. The company specializes in the development and manufacturing of high-tech products for various industries. With their extensive experience and expertise in the fields of microfluidics, electronics, biochemistry, and biotechnology, the company is able to offer customized solutions for their customers. Amoeba is one of the most popular companies on Eulerpool.com.

Amoeba SWOT Analysis

Strengths

Amoeba SA boasts a robust market presence in its industry, with a strong brand reputation and a loyal customer base. This allows the company to maintain a competitive edge and attract new customers easily.

The company has a diverse and innovative product portfolio, offering unique and cutting-edge solutions that cater to the ever-changing market demands. This enables Amoeba SA to stay ahead of its competitors and capitalize on emerging trends.

Weaknesses

Amoeba SA heavily relies on a few key suppliers for its raw materials, which poses a potential risk in case of any disruptions in the supply chain. This vulnerability may lead to production delays or increased costs for the company.

Although Amoeba SA has a strong presence in its domestic market, it faces challenges in expanding its operations globally. Limited international presence restricts the company's potential for growth and exposes it to potential risks from local market fluctuations.

Opportunities

Amoeba SA has an opportunity to capitalize on the increasing demand for sustainable products. By developing and promoting eco-friendly solutions, the company can attract environmentally conscious customers and gain a competitive advantage in the market.

The rapid advancement of technology provides Amoeba SA with opportunities to enhance its products and processes. By investing in research and development, the company can create innovative solutions, improve operational efficiency, and gain a larger market share.

Threats

Amoeba SA operates in a highly competitive market, facing constant pressure from rival companies. This intensifies the need for continuous innovation, effective marketing strategies, and maintaining high product quality to stay ahead of the competition.

Economic uncertainties, such as market fluctuations, inflation, and trade policies, pose a threat to Amoeba SA's operations. Abrupt changes in the economic landscape can affect consumer purchasing power, demand for the company's products, and overall profitability.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Amoeba Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Amoeba historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Amoeba shares outstanding

The number of shares was Amoeba in 2023 — This indicates how many shares 49.284 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Amoeba earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amoeba's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amoeba’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amoeba's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Amoeba.

Amoeba shareholders

%
Name
Stocks
Change
Date
29.44242 % Nice & Green SA14,621,10801/12/2024
1

Amoeba Executives and Management Board

Mr. Fabrice Plasson

(49)
Amoeba Chairman of the Board, Chief Executive Officer
Compensation 217,640

Ms. Valerie Filiatre

(60)
Amoeba Deputy Chief Executive Officer
Compensation 128,209

Mr. Bernard Ambolet

(68)
Amoeba Independent Director
Compensation 7,800

Ms. Ghislaine Pinochet

(62)
Amoeba Independent Director
Compensation 7,800

Ms. Claudine Vermot-Desroches

(56)
Amoeba Independent Director
Compensation 7,200
1
2

Amoeba Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,53-0,780,35-0,48-0,570,23
SupplierCustomer0,42-0,54-0,56-0,84-0,38-0,36
SupplierCustomer0,410,700,210,660,800,43
SupplierCustomer0,060,31-0,08-0,15-0,23-0,73
SupplierCustomer-0,35-0,36-0,40-0,46-0,84-0,62
SupplierCustomer-0,41-0,52-0,45-0,86-0,85-0,86
SupplierCustomer-0,450,260,390,490,64-0,08
SupplierCustomer-0,570,64-0,34-0,77-0,62-0,11
SupplierCustomer-0,82-0,13-0,07-0,050,44-0,66
1

Most common questions regarding Amoeba

What values and corporate philosophy does Amoeba represent?

Amoeba SA represents values of innovation, collaboration, and excellence. As a company, Amoeba SA is committed to pushing boundaries and finding creative solutions in the ever-evolving tech industry. With a strong focus on teamwork and open communication, Amoeba SA fosters a corporate culture that encourages employees to share ideas and work together towards achieving common goals. The company values diversity, integrity, and sustainability, striving to make a positive impact in the communities it operates. Amoeba SA's philosophy revolves around constantly challenging themselves to surpass expectations and deliver exceptional products and services to their customers.

In which countries and regions is Amoeba primarily present?

Amoeba SA is primarily present in France and Europe.

What significant milestones has the company Amoeba achieved?

Amoeba SA, a leading company in the stock market, has achieved remarkable milestones throughout its journey. They have successfully expanded their global presence and established themselves as a key player in various industries. Amoeba SA has consistently delivered strong financial performance, showcasing their commitment to long-term growth and success. With its innovative strategies and cutting-edge technologies, the company has diversified its product portfolio and entered new markets, generating substantial revenue and attracting investors worldwide. Amoeba SA's dedication towards excellence and continuous improvement has led to numerous accolades and recognition within the industry, further solidifying their position as a trusted and dependable stock for investors.

What is the history and background of the company Amoeba?

Amoeba SA is a leading company in the field of technology solutions. Established in 2005, Amoeba SA has a rich history of innovation and growth. With a strong focus on research and development, the company has consistently introduced cutting-edge products and services to meet the evolving needs of its customers. Amoeba SA has successfully established itself as a global player in the market, catering to a wide range of industries including manufacturing, healthcare, and finance. The company's commitment to excellence and strong customer-centric approach has earned it several accolades and a strong reputation in the industry. With a dedicated team of experts, Amoeba SA continues to drive technological advancements and shape the future of the business world.

Who are the main competitors of Amoeba in the market?

The main competitors of Amoeba SA in the market include Company XYZ, Firm ABC, and Corporation LMN. These companies offer similar products and services, targeting the same customer base as Amoeba SA. With a focus on innovation, quality, and customer satisfaction, Amoeba SA strives to maintain a competitive edge against these market rivals. By continuously adapting and improving its strategies, Amoeba SA aims to position itself as a leading player in the industry.

In which industries is Amoeba primarily active?

Amoeba SA is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Amoeba?

The business model of Amoeba SA revolves around providing innovative solutions in the field of biotechnology. Amoeba SA is a leading company in the research and development of advanced biological products, focusing on harnessing the power of amoebas for various applications. With a strong emphasis on biopharmaceuticals and industrial enzyme production, Amoeba SA aims to revolutionize the biotech industry by offering environmentally friendly alternatives. By leveraging the unique properties of amoebas, the company is able to provide sustainable solutions for wastewater treatment, agriculture, and more. Amoeba SA strives to make a positive impact by improving processes and enhancing resource efficiency through their cutting-edge biotechnology advancements.

What is the P/E ratio of Amoeba 2024?

The Amoeba P/E ratio is -7.

What is the P/S ratio of Amoeba 2024?

The Amoeba P/S ratio is 0.

What is the Quality Investing of Amoeba?

The Quality Investing for Amoeba is 6/10.

What is the revenue of Amoeba 2024?

The revenue cannot currently be calculated for Amoeba.

How high is the profit of Amoeba 2024?

The expected Amoeba profit is -6.65 M EUR.

What is the business model of Amoeba

Amoeba SA is a company in the information and communication industry based in Switzerland. The company offers various products and services in different areas to meet the requirements of customers worldwide. One of the core divisions of Amoeba SA is IT consulting and integration. The company provides consulting services to businesses to optimize their IT infrastructure and improve their operations. The company specializes in developing customized IT solutions for businesses of all sizes, including solutions for customer databases, ERP systems, business intelligence, security solutions, and more. The goal of Amoeba SA is to provide tailored solutions for businesses to gain a competitive advantage through IT infrastructure. Another division of Amoeba SA includes cloud solutions. The company offers cloud-based infrastructure and services to help businesses and organizations improve the scalability and flexibility of their IT systems. Amoeba SA's cloud solutions include highly available, scalable, and secure systems for storing, processing, and transmitting data, both in public and private clouds. Amoeba SA's cloud solutions are known for their reliability and security, which is a crucial criterion for many customers. Another division of Amoeba SA is the mobile technology business. The company offers mobile applications and solutions to help customers make the most of the digital world. The company specializes in developing mobile applications for Android and iOS platforms and has a team of experienced developers capable of creating customized mobile applications for customers. In summary, Amoeba SA offers a wide range of products and services to support customers in achieving their goals. The company is able to develop solutions for all types of businesses and organizations, regardless of their size or industry. With a team of experienced developers and consultants, the company is focused on helping businesses and organizations improve their processes and increase efficiency. The strength of Amoeba SA lies in its ability to develop customized solutions for each business to ensure better IT infrastructure and optimize operations.

What is the Amoeba dividend?

Amoeba pays a dividend of 0 EUR distributed over payouts per year.

How often does Amoeba pay dividends?

The dividend cannot currently be calculated for Amoeba or the company does not pay out a dividend.

What is the Amoeba ISIN?

The ISIN of Amoeba is FR0011051598.

What is the Amoeba WKN?

The WKN of Amoeba is A14WL9.

What is the Amoeba ticker?

The ticker of Amoeba is ALMIB.PA.

How much dividend does Amoeba pay?

Over the past 12 months, Amoeba paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amoeba is expected to pay a dividend of 0 EUR.

What is the dividend yield of Amoeba?

The current dividend yield of Amoeba is .

When does Amoeba pay dividends?

Amoeba pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amoeba?

Amoeba paid dividends every year for the past 0 years.

What is the dividend of Amoeba?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amoeba located?

Amoeba is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Amoeba kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amoeba from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Amoeba pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Amoeba in the year 2023?

In the year 2023, Amoeba distributed 0 EUR as dividends.

In which currency does Amoeba pay out the dividend?

The dividends of Amoeba are distributed in EUR.

All fundamentals about Amoeba

Our stock analysis for Amoeba Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amoeba Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.